Noah G. Levy is Director at MERRIMACK PHARMACEUTICALS INC (MACK). They have made 7 open-market trades across 1 company since 2020, most recently 2023-01-03.
CIK 0001788608
7 open-market purchases totalling $552K since 2020, never a sale. Across 7 scored buys the stock is down 19.1% at ninety days, and 19.7 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MACK | 1,014,286 | $15.3M |
Shares reported on the most recent Form 4, priced at the 2023-01-04 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 43% | 29% |
| Avg Move | +4.2% | -7.0% | -19.1% |
| Alpha | +1.1% | -12.1% | -19.7% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MACK | BUY | 2022-12-30 | 2023-01-04 | $11.24 | $74K | -0.7% | +0.3% | +2.9% |
| MACK | BUY | 2022-07-13 | 2022-07-15 | $5.89 | $18K | -14.2% | -28.5% | -43.4% |
| MACK | BUY | 2022-07-07 | 2022-07-11 | $5.99 | $15K | -2.5% | -27.3% | -49.6% |
| MACK | BUY | 2022-06-30 | 2022-07-05 | $5.76 | $9K | -4.8% | -28.8% | -39.2% |
| MACK | BUY | 2022-06-10 | 2022-06-14 | $5.06 | $81K | +14.9% | +10.0% | -15.6% |
| MACK | BUY | 2022-01-26 | 2022-01-28 | $4.92 | $353K | +34.8% | +32.5% | +23.1% |
| MACK | BUY | 2020-08-13 | 2020-08-17 | $3.50 | $2K | +1.9% | -7.2% | -11.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.